ranibizumab intravitreal injection

BIOLOGICAL2 trials

Sponsors

Hawaii Pacific Health, GlaxoSmithKline

Conditions

Macular DegenerationPolypoidal Choroidal Vasculopathy

Phase 1

Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)

CompletedNCT00424710

Hawaii Pacific HealthPolypoidal Choroidal Vasculopathy

Start: 2007-01-31End: 2010-09-30Updated: 2014-11-05

Phase 2

Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration

CompletedNCT01134055

GlaxoSmithKlineMacular Degeneration

Start: 2010-06-01End: 2012-10-01Updated: 2018-01-08